SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 28th, 2017 • Selecta Biosciences Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 28th, 2017 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 26, 2017 by and among Selecta Biosciences, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 28th, 2017 • Selecta Biosciences Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 28th, 2017 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 26, 2017 by and among Selecta Biosciences, Inc., a Delaware corporation (the “Company”), and Timothy Springer, Ph.D. (the “Investor”).